CD274 and pancreatic neoplasm: Tessier-Cloutier et al. demonstrated that increased PD-L1 expression (>10%) detected by immunohistochemistry was associated with poor disease-specific survival in resected pancreatic cancer patients (median 0.61 years vs. 1.52 years, P = 0.027)11.